The advisory board supports the company scientifically and gives advice for the implementation, dissemination and exploitation of the company's products. The advisory board currently has 6 members. They are introduced below.

Photo of Prof. Dr. Dr. Rudy De Wilde

Prof. Dr. Dr. Rudy Leon De Wilde, MD, ScD, PhD

Professor Rudy Leon De Wilde is the Medical Director of the Clinic for Obstetrics, Gynecology and Gynecological Oncology at the Pius-Clinic Oldenburg and he is the Head of the University Clinic for Gynecology of the Faculty of Medicine and Health Science of the Carl von Ossietzky University Oldenburg. He is also the Chief Medical Officer of the Pius-Clinic and a Professor at the Universities of Göttingen and Bochum. Prof. De Wilde studied medicine at the Catholic University of Leuven in Belgium and earned his medical doctorate from the University of Bochum. He completed a residency and specialization in obstetrics and gynecology in Germany and a residency and specialization in microsurgery in Leuven.

Prof. De Wilde is a prolific author and speaker on many specialized topics in his field, including endocrinology, major gynecological operations, operative gynecological endoscopy, and gynecological oncology. He published more than 140 articles on operative gynecology and is also the recipient of numerous international scientific prizes for experimental surgery, microsurgery, breast surgery, plastic and reconstructive surgery and gynecologic and oncologic surgery.  Prof. De Wilde is on the editorial board of Gynecologic Surgery and an ad hoc reviewer of the Journal of the American Society of Gynecological Laparoscopists. He is the president of the European Society of Gynecological Endoscopy as well.


Photo of Prof. Dr. Winfried März

Prof. Dr. Winfried März, M.D.

Prof. Winfried März is a board licensed clinical pathologist and full professor at the Clinical
Institute of Medical and Chemical Laboratory Diagnostics at the Medical University Graz, Austria. He also serves as business development manager and director of the synlab academy at synlab Services GmbH, Augsburg, and is an associated scientist at the Medical Clinic V (Nephrology, Hypertensiology, Rheumatology, Endocrinology and Diabetology), Medical Faculty Mannheim, University of Heidelberg, Germany. His research interests are disorders of lipid metabolism, genetics and epidemiology of heart and kidney diseases and the roles of novel biomarkers in risk prediction. Prof. März has authored and co-authored ~ 650 scientific papers listed in PubMed.

Photo of Prof. Dr. Alexander Rohrbach

Prof. Dr. Alexander Rohrbach, PhD

Prof. Alexander Rohrbach studied physics at the university of Erlangen-Nürnberg in Germany, where he did his diploma in 1994 at the institute of optics. During his PhD in physics in Heidelberg he investigated different kinds of light scattering at the local Kirchhoff-Institute for Physics, as well as evanescent wave microscopy at the Max-Planck-Institute for medical research in Heidelberg. In both cases he worked on applications in cell biology. After his PhD in 1998, he continued his research as a Post-Doc at the European Molecular Biology Laboratory (EMBL) in Heidelberg. He intensified his studies on microscopy, light scattering and optical forces. In 2001 he became project leader of the photonic force microscopy group at EMBL, where he concentrated on the further technical development of this scanning probe microscopy and on applications in biophysics and soft matter physics. In 2005 he was awarded with the habilitation in physics at the university of Heidelberg. Since January 2006 he is full professor for Bio- and Nano-Photonics at IMTEK, Faculty of engineering and since 2007 he is also a member of the physics faculty, University of Freiburg. Within his current biophysical research the nano-mechanics of mouse macrophages and bacteria is investigated, that is their dynamic in consideration of diverse force and energy fluctuations.

Photo of Prof. Dr. Jalid Sehouli

Prof. Dr. Jalid Sehouli, M.D.

Prof. Jalid Sehouli is the director of the Clinic of Gynecology, Charité Campus Virchow Clinic, Berlin; director of the Clinic of Gynecology, Charité Campus Benjamin Franklin, Berlin; Head of the European Competence Center for Ovarian Cancer (EKZE), Charité Campus Virchow Clinic, Berlin as well as Head of the Interdisciplinary Center of Gynecolgical Cancer of the Charité. Prof. Sehouli studied human medicine at the FU Berlin and gained his doctorate for his thesis about the postoperative use of unconventional cancer therapies in gynecologic oncology. Since 2007 he has a professorship for Gynecology at the Charité University Medicine Berlin and since 2014 he has the acceptance of professorship for Gynecology for life at the Charité.

Prof. Sehouli was the director of different phase-I, -II and phase-III trials concerning targeted therapies. Moreover he is a member of several organizations, for example North-Eastern German Society of Gynecological Oncology, American Society of Clinical Oncology (ASCO), German Society of Gynecology and Obstetrics, Centre of Evidence Based Medicine Oxford, official ovarian cancer guideline commission of the AGO and European Society of Gynecological Oncology. Prof. Sehouli is also a reviewer of international and national journals and published more than 350 international publications.


Photo of Prof. Dr. Henning Walczak

Prof Dr. Henning Walczak, PhD

Since 2014 Professor Henning Walczak is the Head of the Department of Cancer Biology of the UCL Cancer Institute of the University College London. He is also the Scientific Director of the Cancer Research UK – UCL Centre and chairs the Centre for Cell Death, Cancer and Inflammation (CCCI) of the UCL Cancer Institute.

Following his PhD in 1995 at the German Cancer Research Centre (DKFZ) in Heidelberg (Germany), Professor Walczak worked as a postdoc at Immunex Corporation in Seattle (WA, USA), before returning to the DKFZ as a group leader in 1998. In 2007 he was appointed Chair of Tumor Immunology at the Imperial College London.

His team, which is funded by Cancer Research UK, the Wellcome Trust and the European Research Council, is internationally recognised for its work on cell death and inflammation, specifically focusing on the biology of death receptor-ligand and the ubiquitin systems.


Photo of Dr. Walter Wolters

Dr. Walter Wolters, PhD

Dr. Walter Wolters studied Chemistry at the TU Berlin and gained his PhD at the Hahn-Meitner-Institute for nuclear research in Berlin-Wannsee. Afterwards he worked as a product manager for Boehringer Mannheim (today Roche Diagnostics) in the pharma division. Dr. Wolters was the leader of the product- and project management for cardiovascular products and was Liason Officer for SmithKline Beecham. Later on he was the leader of „Cooperations and Coordination“ in Business Development and of “Price Committee Pharmaceuticals”. Furthermore, Dr. Wolters was the leader of “International Coordination Production Pharmaceuticals” and director of Pharmaceutical Manufacturing Cooperations. He was also a project leader and quality manager for Roche Molecular Biochemicals. The last project of Roche Applied Science he was responsible for was the integration of bought Start-up companies in the USA in the Roche organization. Dr. Wolters participated in several management trainings and is a consultant for Pharma Consult and Concept Heidelberg.

Just call us:

Monday to Thursday from 9:00 - 16:00
and Friday from 9:00 - 15:00

Our phone number:
+49 6221-8936-157

Send us a message:

We will get back to you as soon as possible.
Your TherapySelect Team


Our Awards

Award for innovative research
Award from the Federal Ministry of Education and Research, Germany
Award from the Federal Ministry for Economic Affairs and Energy of Germany
Award from the European Union